MA26480A1 - Derives de phenoxymethylpiperidine - Google Patents

Derives de phenoxymethylpiperidine

Info

Publication number
MA26480A1
MA26480A1 MA25019A MA25019A MA26480A1 MA 26480 A1 MA26480 A1 MA 26480A1 MA 25019 A MA25019 A MA 25019A MA 25019 A MA25019 A MA 25019A MA 26480 A1 MA26480 A1 MA 26480A1
Authority
MA
Morocco
Prior art keywords
phenoxymethylpiperidine
derivatives
phenoxymethylpiperidine derivatives
Prior art date
Application number
MA25019A
Other languages
English (en)
Inventor
Allen Flippin Lee
Garrett Loughhead David
James Weikert Robert
Lin Xiao-Fa
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA26480A1 publication Critical patent/MA26480A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA25019A 1997-04-03 1998-04-01 Derives de phenoxymethylpiperidine MA26480A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4268197P 1997-04-03 1997-04-03
US6975597P 1997-12-16 1997-12-16

Publications (1)

Publication Number Publication Date
MA26480A1 true MA26480A1 (fr) 2004-12-20

Family

ID=26719512

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25019A MA26480A1 (fr) 1997-04-03 1998-04-01 Derives de phenoxymethylpiperidine

Country Status (13)

Country Link
EP (1) EP0869119A1 (fr)
JP (1) JP2938432B2 (fr)
KR (1) KR100257958B1 (fr)
CN (1) CN1194977A (fr)
AU (1) AU743476B2 (fr)
CA (1) CA2232147A1 (fr)
CZ (1) CZ98898A3 (fr)
HU (1) HUP9800707A3 (fr)
IL (1) IL123860A0 (fr)
MA (1) MA26480A1 (fr)
NO (1) NO310354B1 (fr)
NZ (1) NZ330017A (fr)
PL (1) PL325687A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808015D0 (en) * 1998-04-15 1998-06-17 United Medical And Dental Scho Protection of the nervous system from the effects of inflammatory disease
US6420354B1 (en) 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
DE19907385A1 (de) * 1999-02-20 2000-08-24 Boehringer Ingelheim Pharma Neue substituierte 3-Phenoxy- und 3-Phenylalkyloxy-2-phenyl-propylamine
EP1182193A4 (fr) 1999-04-09 2002-09-11 Mochida Pharm Co Ltd Remedes pour douleurs neurogenes
US6479498B1 (en) 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
US6756400B2 (en) 2000-08-31 2004-06-29 Theravance, Inc. Sodium channel modulators
AU2002236775A1 (en) 2001-01-16 2002-07-30 Seok-Ki Choi Sodium channel modulators
JPWO2004011430A1 (ja) * 2002-07-25 2005-11-24 アステラス製薬株式会社 ナトリウムチャネル阻害剤
GB0218827D0 (en) * 2002-08-13 2002-09-18 Syngenix Ltd Anaesthetic compounds and conjugates thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1203149A (en) * 1968-06-10 1970-08-26 Ici Ltd Piperidine derivatives
MX9100517A (es) * 1990-08-06 1992-04-01 Smith Kline French Lab Compuestos
FR2667317B1 (fr) * 1990-10-02 1992-12-04 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
GB9226111D0 (en) * 1992-12-15 1993-02-10 Smithkline Beecham Plc Madicaments

Also Published As

Publication number Publication date
AU5937998A (en) 1998-10-08
KR100257958B1 (ko) 2000-07-01
JPH10287649A (ja) 1998-10-27
CN1194977A (zh) 1998-10-07
IL123860A0 (en) 1998-10-30
NZ330017A (en) 1999-04-29
NO310354B1 (no) 2001-06-25
JP2938432B2 (ja) 1999-08-23
PL325687A1 (en) 1998-10-12
AU743476B2 (en) 2002-01-24
HU9800707D0 (en) 1998-05-28
HUP9800707A2 (hu) 1999-05-28
HUP9800707A3 (en) 1999-06-28
CA2232147A1 (fr) 1998-10-03
CZ98898A3 (cs) 1998-10-14
NO981495L (no) 1998-10-05
KR19980081053A (ko) 1998-11-25
NO981495D0 (no) 1998-04-02
EP0869119A1 (fr) 1998-10-07

Similar Documents

Publication Publication Date Title
PT1005446E (pt) Derivados de n-aroilfenilalanina
ATE235220T1 (de) Resorcinderivate
ID22781A (id) Turunan-turunan nikotinamida
PT934320E (pt) Derivados de naftiridina
DE69817186D1 (de) Diaminorhodamin-derivate
BR9708386A (pt) Derivados de 6-fenilpiridil-2-amina
PT915088E (pt) Derivados de d-prolina
DE69735712D1 (de) Aryl-pyrimidin-derivate
PT930302E (pt) Derivados de benzo-sulfona
NO981946D0 (no) Imidazoquinazolin-derivater
PT1104422E (pt) Derivados de fenilxantina
ATE255098T1 (de) Substituierte chromanderivate
PT1003719E (pt) Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
PT1027362E (pt) Derivados de cetolidos 2-halogeno-6-o-substituidos
BR9709065A (pt) Derivados de alquilaminobenzotiazole e-benzoxazol
PT928790E (pt) Derivados de tiazolo
DE69841086D1 (de) 5-Deoxy-Cytidin-Derivate
ATE255099T1 (de) Substituierte chromanderivate
PT1056716E (pt) Derivados de ciclo-hexanodiolo
IS5026A (is) 2-metoxýfenýlpíperasín afleiður
ATE292632T1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin- derivate
MA26480A1 (fr) Derives de phenoxymethylpiperidine
DE69828780D1 (de) Amidinocamptpthecin-derivate
PT906279E (pt) Derivados de pirrol